IMAX (IMAX) CEO trades 25,024 shares in 10b5-1 option exercises
IMAX CEO Richard L. Gelfond exercised stock options and sold 25,024 common shares in pre-planned transactions under a Rule 10b5-1 Plan. He converted the options at an exercise price of $31.40 per share and sold the shares in open-market trades at prices of $40.0034 and $40.2621 per share. Following these transactions, Mr. Gelfond directly holds 765,002 common shares, along with remaining balances of 1,672,451 stock options and 231,562 restricted share units.
IMAX (NYSE: IMAX) Form 144: Gelfond sold 121,220 shares, plans 12,987
IMAX filed a Form 144 notice disclosing that Richard Gelfond plans to sell 12,987 shares of common stock acquired as compensation via a cashless exercise/same-day sale. The filing also revealed prior sales by Gelfond, including 121,220 shares on March 10, 2026, for over $4.8 million, and 12,037 shares on April 2, 2026, for over $481,000. These transactions are detailed with key figures like planned and prior sale amounts and proceeds.
IMAX (IMAX) China CEO exercises RSUs as 4,790 shares withheld for tax
Daniel Manwaring, CEO of IMAX China Holding, transparently reported stock-based compensation activity on March 7, 2026, including exercising 12,075 restricted share units (RSUs) and receiving a new grant of 5,072 RSUs. To fulfill tax obligations for these transactions, IMAX Corporation withheld 4,790 common shares at $40.80 per share. After these movements, Manwaring holds 12,363 common shares and 21,816 restricted share units, reflecting his equity stake in the company.
IMAX CORP (NYSE:IMAX) Meets Key Criteria of the Minervini Trend Template
IMAX CORP (NYSE:IMAX) is identified as a stock meeting the Minervini Trend Template, indicating strong technical and fundamental performance. The article highlights IMAX's clear uptrend, superior relative strength, and robust earnings growth, making it a candidate for high-growth, momentum-focused investors. However, it advises caution for immediate entry due to recent price instability, suggesting waiting for a clearer setup.
Imax Corp stock: Up nearly 4% in April amid cinema rebound?
Imax Corp shares have risen nearly 4% in early April 2026, driven by renewed investor confidence in the cinema rebound and the company's strong business model focusing on premium large-format experiences. Analysts maintain an "Outperform" rating, citing Imax's technological edge and exclusive content deals. For North American investors, Imax offers exposure to the robust U.S. box office, but potential risks include box office volatility and insider trading activities.
Imax Corp stock: Up nearly 4% in April amid cinema rebound?
Imax Corp shares have risen nearly 4% in early April 2026, driven by a rebound in cinema attendance and the company's strong positioning in premium large-format entertainment. The article highlights Imax's business model, recent stock momentum, analyst perspectives, and key risks for North American investors, emphasizing its technological edge and exclusive content deals. Investors are advised to monitor Q1 2026 earnings and major film releases for further insights.
IMAX Corporation (IMAX) stock price, news, quote and history
This article provides comprehensive financial information for IMAX Corporation (IMAX), including its current stock price, recent performance, key financial metrics, and company overview. It highlights IMAX's global operations as a technology platform for entertainment, detailing its Content Solutions and Technology Products and Services segments. The report also includes analyst insights, earnings trends, and comparisons with similar companies in the entertainment industry.
IMAX (NYSE: IMAX) director Richard Gelfond sells 121,220 shares for $4.86M
IMAX director Richard Gelfond sold 121,220 shares of common stock for an aggregate value of $4.86 million on March 10, 2026. This transaction was reported on a Form 144 as a cashless exercise/same-day sale, related to stock options acquired in 2016. The sale represents a small percentage of IMAX's outstanding shares.
Imax Corp (IMAX) Shares Up 2.85% on Apr 2
Imax Corp (IMAX) shares rose 2.85% on April 2, reaching $39.74, placing it 7.92% below its 52-week high. Wall Street analysts have an average target price of $45.45 for IMAX, suggesting a 14.38% upside, while GuruFocus estimates a GF Value of $26.39, indicating a potential 33.59% downside. The stock's average brokerage recommendation is "Outperform."
Imax CEO Richard Gelfond Taking Temporary Medical Leave
Imax CEO Richard Gelfond is taking a temporary medical leave to receive treatment for pneumonia. During his absence, senior executives will manage day-to-day responsibilities in coordination with board chairman Darren Throop, with regular updates to the board. The company announced this to ensure transparency and avoid speculation as Gelfond will miss upcoming events, including industry conferences like CinemaCon.
IMAX CEO takes medical leave for pneumonia treatment By Investing.com
IMAX Corporation CEO Richard Gelfond has taken a temporary medical leave to receive treatment for pneumonia. During his absence, the company's senior executive team, in coordination with Board Chairman Darren Throop, will manage day-to-day operations. IMAX assured that it is in a stable financial position, with recent positive reports including strong box office performance for "Project Hail Mary" and raised price targets from analysts like Benchmark and Rosenblatt.
IMAX Stock Slides After-Hours As CEO Goes On Temporary Leave Of Absence
IMAX CEO Richard Gelfond has taken a temporary medical leave of absence to receive treatment for pneumonia, causing the company's stock to fall 2% in after-hours trading. During his absence, senior executives will manage day-to-day operations in coordination with Board Chairman Darren Throop. Analyst firms like Goldman Sachs, B. Riley, and JPMorgan recently raised their price targets for IMAX, maintaining positive ratings.
IMAX (IMAX) CEO Takes Medical Leave Due to Pneumonia
IMAX CEO Richard Gelfond is taking a temporary medical leave to receive treatment for pneumonia, with the company releasing this information for transparency ahead of his absence from upcoming events. IMAX, a leader in immersive entertainment technology with robust financial health, boasts significant revenue growth and profitability. While it shows strong financial metrics and positive analyst sentiment, potential risks include insider selling activity and industry cyclicality.
IMAX (IMAX) CEO Gelfond on medical leave as veteran team runs operations
IMAX Corporation announced that its CEO, Richard Gelfond, is taking a temporary medical leave of absence to receive treatment for pneumonia. During his absence, a team of veteran senior executives, including CFO Natasha Fernandes and Chief Legal Officer Rob Lister, will manage day-to-day operations in conjunction with Board Chair Darren Throop. The company issued this statement to prevent speculation about Gelfond's absence from upcoming events and emphasized maintaining stability and continuity.
IMAX CEO takes medical leave for pneumonia treatment By Investing.com
IMAX Corporation announced that CEO Richard Gelfond has taken a temporary medical leave to treat pneumonia. During his absence, a senior executive team, in coordination with Board Chairman Darren Throop and the Board of Directors, will manage day-to-day operations. The company assures stakeholders of its financial stability and will provide updates on Gelfond's recovery as appropriate, while maintaining his privacy.
IMAX CEO Richard Gelfond takes medical leave for pneumonia treatment
IMAX CEO Richard Gelfond has taken a temporary medical leave of absence to receive treatment for pneumonia. The company's senior executive team, in coordination with Board Chairman Darren Throop, will manage day-to-day operations during his recovery. IMAX stated it will provide updates as appropriate, emphasizing that the executive team is focused on the company's continued growth and success.
Pneumonia sidelines IMAX CEO as senior team runs day to day
IMAX Corporation announced that CEO Richard Gelfond is taking a temporary medical leave of absence to undergo treatment for pneumonia. During his recovery, a strong senior executive team, including Chief Financial Officer Natasha Fernandes and Chairman Darren Throop, will manage the company's day-to-day operations. IMAX is providing this transparency to prevent speculation ahead of Gelfond's absence from upcoming industry events, assuring stakeholders of continued growth and stability.
Imax Corp Stock: Leading Premium Cinema Technology with Global Reach and Steady Growth Potential
Imax Corp, a leader in premium cinema technology, provides laser projection and giant screen systems globally, positioning it as a key investment for North American investors interested in the theatrical recovery and technological innovation. The company's business model includes equipment sales, maintenance, and a share of box office receipts, driven by proprietary technology and partnerships with major studios and theater chains. While offering growth potential through a capital-light strategy and investment in R&D, investors should consider risks like box office volatility, geopolitical tensions, and competition from home entertainment.
Amazon/MGM Studios’ ‘Project Hail Mary’ Connects With AMC Theatres, Imax
Amazon MGM Studios' sci-fi film "Project Hail Mary," starring Ryan Gosling, has achieved the biggest opening weekend at AMC Theatres and Imax screens in 2026 to date, generating over $140 million globally. AMC reported a significant increase in global admissions, and Imax highlighted the film's strong performance, especially given its stunning depiction of space. Both companies expressed confidence in the film's success contributing to a strong year for theatrical moviegoing.
On 1% of screens, IMAX drove 20% of ‘Project Hail Mary’ debut
IMAX announced a successful opening weekend for Amazon/MGM’s “Project Hail Mary,” generating $28 million globally. The film achieved an impressive $16.4 million domestically, accounting for 20% of its North American debut on just 1% of the total screens. This strong performance highlights IMAX's significant impact on major film releases and its continued connection with space-themed content.
IMAX Earning Date, Earning Analysis and Earning Prediction
This article provides an earnings analysis and prediction for IMAX, detailing past quarterly results and future estimates for revenue and EPS. It highlights how analyst revisions in these estimates correlate with stock price movements and discusses historical stock performance around earnings report dates. The article concludes with an outlook for IMAX's Q4 2025 earnings call, anticipating a positive impact on stock price due to strong financial performance and strategic focus.
IMAX Board Member Sells Shares: March 2026 Transaction Details - News and Statistics
IMAX board member Kevin Douglas sold 568,000 shares of the company, totaling approximately $21.5 million in value, on March 16, 2026. The shares were sold in both direct and indirect holdings, with Douglas retaining over 5.3 million shares after the transaction. This marks his only open-market sale since June 2023, occurring after a period of share price increase for IMAX.
IMAX SEC Filings - Imax Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for IMAX (IMAX) SEC filings, including annual 10-K reports, quarterly 10-Q reports, and 8-K material event disclosures. It details recent financial activities such as the issuance of convertible senior notes, a credit agreement amendment, and quarterly earnings performance, alongside insider trading reports. The platform offers real-time access to filings and AI-powered summaries to help investors understand key terms and implications.
Douglas group trims IMAX (IMAX) stake in 568,000-share Rule 144 block trade
The Douglas family and related trusts have reduced their stake in IMAX Corporation (IMAX) by selling 568,000 common shares in a Rule 144 block trade at $37.82 per share on March 16, 2026. Despite this sale, the group, including Kevin Douglas and Michelle Douglas, remains a significant shareholder, collectively holding substantial portions of the company's common stock. This transaction primarily serves to update ownership disclosures, with no other share transactions reported by the group in the last 60 days.
Douglas-linked entities trim IMAX (NYSE: IMAX) stake with 568K-share sale
Entities associated with Kevin Douglas, a director and 10% owner of IMAX Corp, sold a combined 568,000 shares of IMAX common stock on March 16, 2026, at $37.82 per share. This transaction, representing about 6.5% of Douglas's total IMAX holdings, was an open-market sale. Despite the sale, Douglas and his related entities retain substantial positions in IMAX.
StoneX (NYSE) files Form 144: Proposed sale of IMAX (IMAX) shares
StoneX Financial Inc. has filed a Form 144, indicating proposed sales of Common Shares of IMAX Corporation. The filing details proposed sales of 400,000, 80,000, and 120,000 shares acquired in December 2007 through open market purchases. This notice signifies intent to sell and does not confirm completed transactions.
IMAX (IMAX) CFO nets more shares after RSU and PSU vesting
IMAX Corporation's Chief Financial Officer and EVP Natasha Fernandes reported equity compensation transactions. She exercised restricted and performance stock units, converting them into 20,496 common shares, and also received new grants of restricted share units. To cover tax obligations, the company withheld 28,044 common shares.
IMAX (IMAX) CEO exercises options, sells 121,220 shares under 10b5-1 plan
IMAX CEO Richard L. Gelfond exercised stock options for 121,220 common shares at $31.40 per share and subsequently sold all of them at an average price of $40.0993 per share. These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan. Following these sales, Gelfond retains a substantial equity stake, holding 765,002 common shares, along with additional stock options and restricted share units.
[144] IMAX CORP SEC Filing
This SEC Form 144 filing from IMAX Corp details a proposed sale of securities, indicating that 121,220 shares of common stock, valued at approximately $4.8 million, are to be sold through Goldman Sachs & Co. LLC. The shares were acquired as compensation in the form of stock options in 2016. The filing notes a neutral impact and sentiment, with the transaction expected to occur around March 10, 2026.
IMAX, SharkNinja, and Sonos: Which Premium Consumer Stock Deserves Your Attention in March 2026?
This article compares three premium consumer brands: Sonos, SharkNinja, and IMAX, evaluating their recent financial performance and future prospects. Sonos shows promising profitability but struggles with revenue growth, while SharkNinja boasts strong sales momentum and a significant share repurchase program. IMAX is highlighted as the top pick due to its record-breaking 2025 financials, strong 2026 outlook, and scalable asset-light business model.
IMAX, SharkNinja, and Sonos: Which Premium Consumer Stock Deserves Your Attention in March 2026?
This article analyzes three premium consumer brands—Sonos, SharkNinja, and IMAX—to determine which stock is most compelling for investors in March 2026. Sonos is undergoing a turnaround with improved profitability but faces revenue decline. SharkNinja shows strong growth and a significant share repurchase program, while IMAX delivered a record-breaking 2025 and anticipates an even better 2026 due to an expanded content slate and an asset-light business model. The author concludes that IMAX is the strongest investment among the three.
IMAX (IMAX) legal chief nets 204,875 shares after equity vesting
IMAX Corporation's Chief Legal & Sr Exec VP Robert D. Lister reported multiple equity compensation events on March 7, 2026. These included the conversion of vested restricted share units and performance stock units into 36,950 common shares, along with the withholding of 51,159 common shares at $40.80 per share to cover tax obligations. After these transactions, Lister directly holds 204,875 common shares and 53,272 restricted share units.
IMAX (IMAX) CEO Gelfond reports performance share conversions and tax withholding
IMAX CEO Richard L. Gelfond reported equity award transactions, including the conversion of 196,964 common shares from EBITDA-based performance stock units and 91,768 common shares from TSR-based units, both granted on January 2, 2023. To cover tax withholding obligations, 159,670 common shares were withheld at a price of $40.80 per share. Following these transactions, Gelfond directly holds 765,002 common shares, in addition to outstanding options and restricted stock units.
IMAX Corporation (NYSE:IMAX) Receives Average Rating of "Moderate Buy" from Brokerages
IMAX Corporation (NYSE:IMAX) has received a consensus "Moderate Buy" rating from 11 analysts, with an average 12-month target price of $43.70. The company recently reported strong quarterly earnings, surpassing expectations with an EPS of $0.58 and revenue of $125.21 million, marking a 35.1% year-over-year increase. Various institutional investors have adjusted their holdings in IMAX, which currently has a market capitalization of $2.14 billion.
Jim Cramer Says "IMAX Is Real"
Jim Cramer expressed strong confidence in IMAX Corporation, stating that its theaters are consistently packed and provide a unique experience that encourages people to leave their homes for movies. Orbis Investment Management also highlighted IMAX's value in their Q4 2025 investor letter, noting its scarce technology, global brand, and increasing demand for local language content, reinforcing its strategic importance in the entertainment industry.
Teton Advisors LLC Purchases New Position in IMAX Corporation $IMAX
Teton Advisors LLC has acquired a new position in IMAX Corporation, purchasing 30,000 shares valued at approximately $982,000. This move increases institutional ownership in IMAX to about 93.51%. The investment follows IMAX's strong earnings beat, with EPS of $0.58 against an expected $0.43, and analysts maintaining a "Moderate Buy" rating with an average target price of $43.70.
IMAX Financial Performance & Business Model Analysis 2026 - News and Statistics
IMAX has significantly outperformed the S&P 500 over the past six months, with its stock gaining 38.5% and reaching $41.26. The company, known for its immersive cinema technology, has demonstrated strong financial growth with an annualized revenue growth rate of 24.5% over five years and an expanded margin of 24.3 percentage points. IMAX's free cash flow margin is 20.8%, and its return on invested capital has increased, indicating a less capital-intensive business model.
IMAX CFO to field investor questions at 2026 ROTH event
IMAX Corporation announced that its CFO, Natasha Fernandes, will participate in the 38th Annual ROTH Conference. She will join a fireside chat on March 24th at 2:00 p.m. ET and also meet with investors one-on-one. A live webcast of the fireside chat will be available on the IMAX investor relations website.
IMAX (IMAX): Buy, Sell, or Hold Post Q4 Earnings?
IMAX has seen a significant stock performance, outperforming the S&P 500 by 33.4% in the last six months, driven by solid quarterly results. The article highlights IMAX's strong fundamentals, including impressive annualized revenue growth, increasing free cash flow margins, and a rising return on invested capital. These factors suggest a bullish outlook for the company, prompting investors to consider whether now is the right time to buy its shares.
IMAX PE Ratio & Valuation, Is IMAX Overvalued
This article analyzes IMAX's valuation, concluding that it is currently "Undervalued" based on its forward PS ratio relative to its five-year average. The fair price for IMAX is estimated to be between $48.14 and $60.16, compared to its current price of $42.83. The article also details IMAX's Price-to-Book ratio, Free Cash Flow yield, and compares its P/S ratio to competitors, noting that its premium is sustainable due to strong revenue growth.
Royce & Associates LP Lowers Stock Holdings in IMAX Corporation $IMAX
Royce & Associates LP reduced its holdings in IMAX Corporation by 1.8%, selling 24,931 shares. Despite this, institutional investors collectively own a significant 93.51% of the company's stock. The move comes as IMAX reported strong Q4 earnings, surpassing consensus estimates, and received boosted price targets from analysts, maintaining a "Moderate Buy" rating.
IMAX Corporation 2025 Q4 - Results - Earnings Call Presentation (NYSE:IMAX)
IMAX Corporation reported its Q4 2025 earnings, with an EPS of $0.58, exceeding estimates by $0.11. The company also announced revenue of $125.21 million, which was a 35.11% year-over-year increase and beat estimates by $4.78 million. This report is based on the slide deck published by IMAX Corporation in conjunction with its earnings call.
It’s Fun to Watch Movies In Imax Corporation (IMAX), Says Jim Cramer
Jim Cramer expressed his enjoyment of watching movies in IMAX theaters, highlighting the enhanced experience compared to home viewing, and JPMorgan and Benchmark recently raised their price targets for Imax Corporation (NYSE:IMAX) due to its market share gains and international presence. The company reported strong Q4 2025 revenues of $125 million, marking a 35% annual growth, with full-year revenues reaching $410 million. The article also touches on the broader potential of AI as a significant investment opportunity.
It's Fun to Watch Movies In Imax Corporation (IMAX), Says Jim Cramer
Jim Cramer highlighted that watching movies at Imax Corporation (IMAX) is a fun experience, even better than a home setup. This comes as JPMorgan and Benchmark recently raised their price targets for IMAX, maintaining Overweight and Buy ratings, respectively, following strong Q4 earnings showing 35% annual revenue growth. Despite the positive sentiment for IMAX, the article suggests that some AI stocks may offer potentially higher returns and lower downside risk.
Primecap Management Co. CA Sells 116,100 Shares of IMAX Corporation $IMAX
Primecap Management Co. CA reduced its stake in IMAX Corporation by 15.4%, selling 116,100 shares, but still holds 635,502 shares valued at approximately $20.8 million. This comes after IMAX beat Q4 earnings estimates with $0.58 EPS and $125.2 million in revenue, leading to positive analyst sentiment and a broad "Moderate Buy" rating. The company's stock has seen positive movement, driven by strong box office performance and content diversification, despite potential risks like the "Avengers: Doomsday" opening-weekend windowing issue.
IMAX stock price: shares steady in premarket after 14% pop on upbeat 2026 outlook
IMAX shares were steady in premarket trading after a 14.4% surge, driven by an upbeat 2026 outlook projecting $1.4 billion in global IMAX box office and 160-175 new system installs. Benchmark raised its price target for IMAX to $44, maintaining a buy rating, following the company's "transformational" 2025 performance and ambitious 2026 targets. The positive sentiment is due to strong film slate, increased international installations, and clarification on one-off charges affecting headline profit.
IMAX Corporation (NYSE:IMAX) Q4 2025 Earnings Call Transcript
IMAX Corporation reported record-breaking fourth quarter and full-year results for 2025, with global box office reaching $1.28 billion, up 40% year-over-year. The company achieved record revenue of $410 million and adjusted EBITDA of $185 million, with a 45% margin. IMAX anticipates continued strong performance in 2026, projecting $1.4 billion in global box office and leveraging a robust content slate and strategic network expansion in underserved high-value markets.
IMAX Financials: Income Statement, Balance Sheet & Cash Flow
This article provides a detailed financial overview of Imax Corp (IMAX) for fiscal year 2025, including its income statement, balance sheet, cash flow, and key financial ratios. It highlights strong profitability and cash flow generation despite a significant revenue decline, and assesses the company's financial health with a Piotroski F-Score and earnings quality rating. The financials are derived from SEC filings and updated as of February 25, 2026.
Why Are IMAX (IMAX) Shares Soaring Today
Shares of premium cinema technology company IMAX (NYSE:IMAX) jumped 15.3% after reporting fourth-quarter 2025 results that exceeded Wall Street's expectations for both revenue and profit. The company's revenue grew 35.1% year-on-year to $125.2 million, and adjusted earnings per share more than doubled to $0.58. This strong performance, marked by increased efficiency and operating margin expansion, has fueled investor optimism.
Zhang Financial LLC Acquires New Position in IMAX Corporation $IMAX
Zhang Financial LLC has acquired a new position in IMAX Corporation, purchasing 27,579 shares valued at approximately $903,000. This move comes as IMAX reported strong Q4 results, surpassing expectations thanks to blockbuster films like "Avatar: Fire & Ash" and an expanding content pipeline. Analysts have become more positive on IMAX, though its high P/E ratio and reliance on hit-driven box office performance pose some risks.
